Smoking and HIV associated with subclinical tuberculosis: analysis of a population-based prevalence survey
OBJECTIVE: To quantify the epidemiological burden and estimate associations between individual-level variables and this “subclinical” presentation.
METHODS: We performed a secondary analysis of TB prevalence survey data from the South African communities of the Zambia, South Africa Tuberculosis and AIDS Reduction trial. Generalized estimating equations were used to estimate the association between individual-level demographic, behavioral, socio-economic, and medical variables and the risk of bacteriologically positive TB among participants not reporting any symptoms consistent with active TB.
RESULTS: The crude prevalence of TB was 2222.1 cases per 100 000 population (95% CI 2053.4–2388.5); 44.7% (295/660) of all documented prevalent cases of TB were subclinical. Current tobacco smoking (OR 2.37, 95% CI 1.41–3.99) and HIV-positive status (OR 3.26, 95% CI 2.31–4.61) were significantly associated with subclinical TB.
CONCLUSION: Individuals who smoke or have HIV may be at increased risk of active TB and not report typical symptoms consistent with disease. This suggests possible shortcomings of symptom-based case finding which may need to be addressed in similar settings.
Keywords: South Africa; determinants; incipient TB
Document Type: Research Article
Affiliations: 1: Department of Epidemiology of Microbial Disease 2: Biostatistics, Yale School of Public Health, New Haven, CT, USA 3: ZAMBART, University of Zambia School of Public Health, Lusaka, Zambia, Clinical Research Department, London School of Tropical Medicine & Hygiene, London, UK 4: Clinical Research Department, London School of Tropical Medicine & Hygiene, London, UK 5: Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa
Publication date: March 1, 2020
The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.
The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content